BioSpace News Archive

NS Pharma, Inc. announced today the U.S. Food & Drug Administration (FDA) has granted Orphan Drug Designation to NS-089/NCNP-02, an investigational candidate for patients with Duchenne muscular dystrophy amenable to exon 44 skipping therapy.

NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter 2023 Financial Highlights.

Anavex Life Sciences Corp. today announced a peer-reviewed publication in Clinical Pharmacology in Drug Development.

Collegium Pharmaceutical, Inc. today announced that it has entered into an Accelerated Share Repurchase (“ASR”) agreement with Jefferies LLC to repurchase $50 million of the Company’s common stock.

Viracta Therapeutics, Inc. today announced the appointment of Darrel P. Cohen, M.D., Ph.D. as Chief Medical

Palatin Technologies, Inc. today announced that it has entered a strategic partnership with UpScriptHealth, a leading direct-to-consumer telemedicine company providing telemedicine services to pharmaceutical and medical technology companies.

Ligandal Inc. announces the appointment of Tushar Nuwal as Chief Operating Officer and Chief Business Officer.

MBX Biosciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for MBX 1416, the company’s long-acting glucagon-like peptide 1 (GLP-1) receptor antagonist, being developed for the treatment of post-bariatric hypoglycemia (PBH).

PDS Biotechnology Corporation today announced that the Company will release financial results for the second quarter of 2023 on Monday, August 14, 2023, before the market opens.

Akoya Biosciences , Inc. (Nasqad: AKYA)(“Akoya), The Spatial Biology Company®, today announced a momentous achievement - publication of the 1,000th peer-reviewed article citing use of the company’s technology, the largest publication volume in the industry.